LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 64 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $24,292,000 | +46.7% | 813,800 | -13.9% | 0.01% | +33.3% |
| Q4 2016 | $16,561,000 | -27.9% | 944,700 | -2.2% | 0.01% | -25.0% |
| Q3 2016 | $22,972,000 | +48.7% | 965,600 | 0.0% | 0.01% | +50.0% |
| Q2 2016 | $15,450,000 | -23.5% | 965,600 | 0.0% | 0.01% | -27.3% |
| Q1 2016 | $20,191,000 | -22.6% | 965,600 | 0.0% | 0.01% | -15.4% |
| Q4 2015 | $26,071,000 | +2.9% | 965,600 | +5.9% | 0.01% | 0.0% |
| Q3 2015 | $25,342,000 | +5.0% | 911,900 | -7.4% | 0.01% | +18.2% |
| Q2 2015 | $24,133,000 | +43.3% | 984,600 | +7.0% | 0.01% | +37.5% |
| Q1 2015 | $16,843,000 | -0.8% | 920,400 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $16,981,000 | +92.0% | 920,400 | 0.0% | 0.01% | +100.0% |
| Q3 2014 | $8,845,000 | +4.7% | 920,400 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $8,449,000 | – | 920,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,872,130 | $77,548,000 | 30.77% |
| RTW INVESTMENTS, LP | 1,084,416 | $29,279,000 | 9.67% |
| Avoro Capital Advisors LLC | 784,199 | $21,173,000 | 7.29% |
| Broadfin Capital, LLC | 1,165,373 | $31,465,000 | 1.94% |
| P.A.W. CAPITAL CORP | 50,400 | $1,361,000 | 1.54% |
| Belmont Global Advisors, Inc. | 37,522 | $1,013,000 | 1.31% |
| Perceptive Advisors | 649,515 | $17,537,000 | 1.30% |
| ACUTA CAPITAL PARTNERS, LLC | 82,920 | $2,239,000 | 1.07% |
| Iguana Healthcare Management, LLC | 110,000 | $2,970,000 | 0.98% |
| Virtus ETF Advisers LLC | 10,250 | $277,000 | 0.76% |